Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy—a long-term radiological follow-up

Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy

Clarita V. Odvina, Joseph E. Zerwekh, D. Sudhaker Rao et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 1.4K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Dennis M. Black, Ian R. Reid, Steven Boonen et al. · Journal of Bone and Mineral Research · 2011 · 695 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +10

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

Andrew S. Neviaser, Joseph M. Lane, Brett A. Lenart et al. · Journal of Orthopaedic Trauma · 2008 · 525 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

Ernest Beng Kee Kwek, Seo Kiat Goh, Joyce Suang Bee Koh et al. · Injury · 2008 · 443 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +8

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

Nelson B. Watts, John P. Bilezikian, Susan L. Greenspan et al. · Endocrine Practice · 2010 · 440 citations · Full text

Medicine, Endocrinology, Bone Metabolism +15